Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↑ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|
| NAMSNewAmsterdam Pharma Co N.V. | 2025 | 24 | $2.58B | $21.58 | +1.48% | — | -26.09% | -39.71% | -905.74% | 1 |